Signant Health
Private Company
Total funding raised: $135M
Overview
Signant Health is a leading, established player in the digital health and eClinical solutions sector, providing a comprehensive suite of software and services to streamline clinical trial data collection and management. With 30 years of operational heritage, the company supports thousands of trials and has contributed to hundreds of drug approvals, emphasizing scientific expertise, scalable technology, and high-touch service. Its core value proposition is delivering reliable, high-quality evidence to accelerate the path to regulatory proof for new therapies across all therapeutic areas.
Technology Platform
Unified eClinical Platform comprising Electronic Data Capture (EDC), Electronic Clinical Outcome Assessments (eCOA/ePRO), Randomization & Trial Supply Management (RTSM), eConsent, and TeleVisit modules, supporting decentralized, hybrid, and traditional clinical trials.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Signant operates in a highly competitive market with major players like Veeva Systems (Veeva Vault EDC), Medidata Solutions (a Dassault Systèmes company), and Oracle Health. Its differentiation is based on a unified platform, deep therapeutic and scientific expertise, and a strong service orientation. Competition is based on technology functionality, integration, ease of use, global scale, and total cost of ownership.